BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  ASCO15: TG Therapeutics, Inc. Announces Presentations Of Its Proprietary Combination Of TG-1101 Plus TGR-1202 As Well As TGR-1202 As A Single Agent In Ongoing Phase I/Ib Dose Escalation Clinical Studies

  June 1, 2015

   · 

  13 min read
• BioCapital

  Personal Genome Diagnostics Launches ImmunoSelect-R For Identification Of Immunogenic Cancer Mutations To Support Immuno-Oncology Drug Development

  June 1, 2015

   · 

  7 min read
• Drug Development

  Caris Life Sciences Paired Tumor Data Identifies Key Driver Mutations And Confirms Tumor Heterogeneity In High-Grade Glioma Samples

  June 1, 2015

   · 

  5 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc. Provides Update On Planned Expansion Of Bavituximab Clinical Program

  June 1, 2015

   · 

  9 min read
• Drug Development

  Immunomedics, Inc. Reports Promising Results With Sacituzumab Govitecan In Patients With Metastatic Gastrointestinal Cancers

  June 1, 2015

   · 

  7 min read
• Drug Development

  ASCO15: VBL Therapeutics Reports Updated Interim Results From Phase II Clinical Trial Of VB-111 In Recurrent Glioblastoma (Rgbm)

  June 1, 2015

   · 

  7 min read
• Genetown

  Inform Genomics Licenses Two US Patents From Taiwan’s National Cheng Kung University Medical College To Advance Development Of Precision Medicine Products

  June 1, 2015

   · 

  4 min read
• Drug Development

  ASCO15: Juno Therapeutics’s Investigational CAR T Cell Product Candidate JCAR014 Demonstrates Encouraging Clinical Responses And Translational Insights In Patients With B-Cell Cancers

  June 1, 2015

   · 

  5 min read
• Drug Development

  ASCO15: Onconova Therapeutics Inc. Presents Clinical Data On Rigosertib In Higher-Risk Myelodysplastic Syndromes (HR-MDS) At The 2015 ASCO Annual Meeting

  June 1, 2015

   · 

  7 min read
• Merus Labs International Inc. Announces Closing Of Exercise Of Over-Allotment Option

  June 1, 2015

   · 

  2 min read